Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial

Introduction Ebola virus disease remains a significant public health concern. For protection from Ebola virus, the main target populations are epidemiologically identified and often include healthcare workers and refugees. These target populations are also routinely offered vaccines for other vaccin...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Alice Packham, Yemisi Takwoingi, Christopher A Green, Julien Nyombayire, Jean Pierre Musabyimana, Claude Muvunyi, Karishma Gokani, Alice E Taylor, Hugor Shema, Ariane Mutabaruka, Siobhan Roche, Claudine Umuhoza
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2025-09-01
Edice:	BMJ Open
On-line přístup:	https://bmjopen.bmj.com/content/15/9/e102898.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!